Stem cell transplantation - Clinical: Pediatric Transplants

 
Su Han Lum, Sujith Samarasinghe, Robert Wynn, et al.
 
The authors of the abstract conclude: 
Younger age was associated with better survival. MFD and MUD had comparable survival in children with FA.
————————————————————————————————————————————————————————
 
 
Chunfu Li, Sixi Liu, Yuelin He, et al.
 
The authors of the abstract conclude: 
The current study proved that the novel DID-HSCT improved the results of both haplo-HSCT and UCBT in TM patients and it is especially suitable for non-malignance diseases with a nice life-expectancy.
————————————————————————————————————————————————————————
 
 
Arnon Nagler, Myriam Labopin, Yener Koc, et al.
 
The authors of the abstract conclude: 
The outcome of adult pts with ALL who underwent non T-cell-depleted haploSCT with PTCy has improved over time with an impressive 2 years OS of 75.5% and only 17.3% NRM rate in the most recent cohort. 
————————————————————————————————————————————————————————
 
 
Eolia Brissot, Myriam Labopin, Boris Afanasyev, et al.
 
The authors of the abstract conclude: 
These results highlight that, in the 10/10 MUD transplant setting, the use of PTCY for GVHD prophylaxis provides similar outcomes to those seen with ATG.
————————————————————————————————————————————————————————
 
 
Su Han Lum, Ali Sobh, Kay Carruthers, et al.
 
The authors of the abstract conclude: 
Outcomes after CD3+TCR alpha-beta/CD19+ depletion are superior to previously used TCD methods. In an experienced centre it is a safe alternative procedure and enables a wide spectrum of PID to be transplanted. The result has led to evolution of donor hierarchy in our centre.